Archive: August 2021

Cases in the Management of Metastatic Colorectal Cancer: Regorafenib as Second-Line Therapy After FOLFOXIRI Plus Bevacizumab in a Patient With a KRAS Mutation

Tanios S. Bekaii-Saab, MD

Regorafenib as Second-Line Therapy After FOLFOXIRI Plus Bevacizumab in a Patient With a KRAS Mutation Tanios S. Bekaii-Saab, MD   Patient Case A 53-year-old woman presented […]

Highlights in Ovarian Cancer From the 2021 American Society of Clinical Oncology Annual Meeting

A Review of Selected Presentations From the 2021 ASCO Annual Meeting • June 4-8, 2021   Niraparib Efficacy and Safety in Patients With BRCA-Mutated Ovarian Cancer: […]

Highlights in Advanced Prostate Cancer From the 2021 American Society of Clinical Oncology Annual Meeting

A Review of Selected Presentations From the 2021 ASCO Annual Meeting • June 4-8, 2021   Phase 3 Study of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant […]

Back to Archive